First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases-Reference-Cited by-同舟云学术

First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases

Published:2016-03 Issue:3 Volume:11 Page:380-390
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Schuler Martin,Wu Yi-Long,Hirsh Vera,O’Byrne Kenneth,Yamamoto Nobuyuki,Mok Tony,Popat Sanjay,Sequist Lecia V.,Massey Dan,Zazulina Victoria,Yang James C.-H.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Current management of brain metastases, with a focus on systemic options;Langer;J Clin Oncol,2005

2. Multidisciplinary management of brain metastases;Eichler;Oncologist,2007

3. Chemotherapy and EGFR tyrosine kinase inhibitors for treatment of brain metastases from non-small-cell lung cancer: survival analysis in 210 patients;Fan;Onco Targets Ther,2013

4. Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small cell lung cancer patients with brain metastases or leptomeningeal disease;Hoffknecht;J Thorac Oncol,2015

5. Whole-brain radiotherapy in the management of brain metastasis;Khuntia;J Clin Oncol,2006

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of upfront craniocerebral radiotherapy and epidermal growth factor receptor-tyrosine kinase inhibitors in patients with epidermal growth factor receptor-positive non-small cell lung cancer with brain metastases;Frontiers in Oncology;2024-01-19

2. Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis;Translational Oncology;2024-01

3. Targeted Inhibitors of EGFR: Structure, Biology, Biomarkers, and Clinical Applications;Cells;2023-12-25

4. Successful treatment of a patient with NSCLC carrying uncommon compound L861Q/G719X epidermal growth factor receptor mutations using Afatinib;Respiratory Medicine Case Reports;2023-12

5. Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC;Scientific Reports;2023-11-21